Share records for a drug-related liver injury research registry
Part of Digestive system clinical trials.
This study puts people with a past drug- or herbal-related liver injury into a research registry. The goal is to better understand why the injury happens so doctors can prevent and recognize it sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A liver specialist believes your liver problem was caused by a medicine or herbal product (HDS/CAM)
- Your liver injury started on or after January 1, 1994, and you are still alive
- There is enough medical information for the study team to confirm the cause
- Before the event, you were only taking one suspect drug or herbal product
- Your lab results showed liver injury on blood tests like AST, ALT, and alkaline phosphatase
- You are willing to give consent and allow access to medical info and blood samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how often drug-induced liver injury occurs and how it affects patients over time. If you join, researchers will track your health to learn more about recovery and long-term outcomes.
This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.
This trial builds a prediction model to identify drug-related liver injury (DILI) by looking at your blood test patterns, timing, and expert diagnosis. It may help improve how doctors recognize this condition earlier and more accurately.
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
This study looks at itching caused by drug-induced liver injury. Researchers want to understand who gets itchy and how bad it is, which could help improve care for people with this condition.
This study compares two methods (RUCAM and RECAM) to better identify what caused a recent liver injury. It may help doctors find the right cause and treatment faster.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.